ACHIEVE LIFE SCIENCES, INC.
For the period ended Dec 31, 2025. Filed Mar 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 24, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney (included on the signature page hereto)
Power of Attorney
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Mark Oki and Richard Stewart, jointly and severally, as such person’s attorneys-in-fact, each with the power of substitution, for such person in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By: /s/ RICHARD STEWART | President, Chief Executive Officer and Director (Principal Executive Officer) | Date: March 24, 2026 |
|---|---|---|
| Richard Stewart | ||
| By: /s/ MARK OKI | Chief Financial Officer (Principal Financial Officer) | Date: March 24, 2026 |
| Mark Oki | ||
| By: /s/ JERRY WAN | Vice President, Finance (Principal Accounting Officer) | Date: March 24, 2026 |
| Jerry Wan | ||
| By: /s/ THOMAS B. KING | Chairman of the Board of Directors | Date: March 24, 2026 |
| Thomas B. King | ||
| By: /s/ BRIDGET MARTELL | Director | Date: March 24, 2026 |
| Bridget Martell | ||
| By: /s/ STUART DUTY | Director | Date: March 24, 2026 |
| Stuart Duty | ||
| By: /s/ THOMAS SELLIG | Director | Date: March 24, 2026 |
| Thomas Sellig | ||
| By: /s/ KRISTEN SLAOUI | Director | Date: March 24, 2026 |
|---|---|---|
| Kristen Slaoui | ||
| By: /s/ NANCY R. PHELAN | Director | Date: March 24, 2026 |
| Nancy R. Phelan | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.